These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
559 related articles for article (PubMed ID: 18585903)
1. Effect of polyethylene glycol on preparation of rifampicin-loaded PLGA microspheres with membrane emulsification technique. Ito F; Fujimori H; Honnami H; Kawakami H; Kanamura K; Makino K Colloids Surf B Biointerfaces; 2008 Oct; 66(1):65-70. PubMed ID: 18585903 [TBL] [Abstract][Full Text] [Related]
2. Preparation and properties of monodispersed rifampicin-loaded poly(lactide-co-glycolide) microspheres. Ito F; Makino K Colloids Surf B Biointerfaces; 2004 Nov; 39(1-2):17-21. PubMed ID: 15542335 [TBL] [Abstract][Full Text] [Related]
3. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery. Doan TV; Couet W; Olivier JC Int J Pharm; 2011 Jul; 414(1-2):112-7. PubMed ID: 21596123 [TBL] [Abstract][Full Text] [Related]
4. Effects of lung surfactants on rifampicin release rate from monodisperse rifampicin-loaded PLGA microspheres. Tomoda K; Makino K Colloids Surf B Biointerfaces; 2007 Mar; 55(1):115-24. PubMed ID: 17197161 [TBL] [Abstract][Full Text] [Related]
5. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization. Doan TV; Olivier JC Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562 [TBL] [Abstract][Full Text] [Related]
6. Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin. Makino K; Nakajima T; Shikamura M; Ito F; Ando S; Kochi C; Inagawa H; Soma G; Terada H Colloids Surf B Biointerfaces; 2004 Jul; 36(1):35-42. PubMed ID: 15261021 [TBL] [Abstract][Full Text] [Related]
7. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis. Ohashi K; Kabasawa T; Ozeki T; Okada H J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349 [TBL] [Abstract][Full Text] [Related]
8. Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis. Hirota K; Hasegawa T; Nakajima T; Inagawa H; Kohchi C; Soma G; Makino K; Terada H J Control Release; 2010 Mar; 142(3):339-46. PubMed ID: 19951729 [TBL] [Abstract][Full Text] [Related]
9. Preparation and properties of PLGA microspheres containing hydrophilic drugs by the SPG (shirasu porous glass) membrane emulsification technique. Ito F; Honnami H; Kawakami H; Kanamura K; Makino K Colloids Surf B Biointerfaces; 2008 Nov; 67(1):20-5. PubMed ID: 18774278 [TBL] [Abstract][Full Text] [Related]
10. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres. Kim JH; Taluja A; Knutson K; Han Bae Y J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769 [TBL] [Abstract][Full Text] [Related]
11. A novel preparation method for PLGA microspheres using non-halogenated solvents. Matsumoto A; Kitazawa T; Murata J; Horikiri Y; Yamahara H J Control Release; 2008 Aug; 129(3):223-7. PubMed ID: 18562036 [TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying. Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422 [TBL] [Abstract][Full Text] [Related]
13. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954 [TBL] [Abstract][Full Text] [Related]
14. Effects of pulmonary surfactant system on rifampicin release from rifampicin-loaded PLGA microspheres. Tomoda K; Kojima S; Kajimoto M; Watanabe D; Nakajima T; Makino K Colloids Surf B Biointerfaces; 2005 Sep; 45(1):1-6. PubMed ID: 16099143 [TBL] [Abstract][Full Text] [Related]
15. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine. Bae SE; Son JS; Park K; Han DK J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089 [TBL] [Abstract][Full Text] [Related]
16. Radiosterilisation of indomethacin PLGA/PEG-derivative microspheres: protective effects of low temperature during gamma-irradiation. Fernández-Carballido A; Puebla P; Herrero-Vanrell R; Pastoriza P Int J Pharm; 2006 Apr; 313(1-2):129-35. PubMed ID: 16495023 [TBL] [Abstract][Full Text] [Related]
17. Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles. Manca ML; Loy G; Zaru M; Fadda AM; Antimisiaris SG Colloids Surf B Biointerfaces; 2008 Dec; 67(2):166-70. PubMed ID: 18835764 [TBL] [Abstract][Full Text] [Related]
18. Fabrication strategy for amphiphilic microcapsules with narrow size distribution by premix membrane emulsification. Wei Y; Wang Y; Wang L; Hao D; Ma G Colloids Surf B Biointerfaces; 2011 Oct; 87(2):399-408. PubMed ID: 21683559 [TBL] [Abstract][Full Text] [Related]
19. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir. Duvvuri S; Janoria KG; Mitra AK J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919 [TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification. Gasparini G; Kosvintsev SR; Stillwell MT; Holdich RG Colloids Surf B Biointerfaces; 2008 Feb; 61(2):199-207. PubMed ID: 17919891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]